Connection
Richard Schulick to Carcinoma, Renal Cell
This is a "connection" page, showing publications Richard Schulick has written about Carcinoma, Renal Cell.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.065 |
|
|
|
-
Kato Y, Yoshimura K, Shin T, Verheul H, Hammers H, Sanni TB, Salumbides BC, Van Erp K, Schulick R, Pili R. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma. Clin Cancer Res. 2007 Aug 01; 13(15 Pt 1):4538-46.
Score: 0.065